Global (United States, European Union and China) Gastrointestinal Drugs Market Research Report 2019-2025

Publisher Name :
Date: 02-Aug-2019
No. of pages: 114
Inquire Before Buying

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

In 2019, the market size of Gastrointestinal Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gastrointestinal Drugs.

This report studies the global market size of Gastrointestinal Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Gastrointestinal Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- AstraZeneca

- Sanofi

- Bayer

- Pfizer

- GlaxoSmithKline

- Teva

- Zeria(Tillotts)

- Perrigo

- Boehringer Ingelheim

- Purdue Pharma

- C.B. Fleet

- Abbott

- Jiangzhong

- Xian-Janssen

Market Segment by Product Type

- Prescription Gastrointestinal Drug

- OTC Gastrointestinal Drug

Market Segment by Application

- Chronic Gastritis

- Functional Dyspepsia

- Peptic Ulcer

- Acute Gastroenteritis

- Other

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Gastrointestinal Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Gastrointestinal Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Gastrointestinal Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Gastrointestinal Drugs Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Prescription Gastrointestinal Drug
1.3.3 OTC Gastrointestinal Drug
1.4 Market Segment by Application
1.4.1 Global Gastrointestinal Drugs Market Share by Application (2019-2025)
1.4.2 Chronic Gastritis
1.4.3 Functional Dyspepsia
1.4.4 Peptic Ulcer
1.4.5 Acute Gastroenteritis
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Drugs Market Size
2.1.1 Global Gastrointestinal Drugs Revenue 2014-2025
2.1.2 Global Gastrointestinal Drugs Sales 2014-2025
2.2 Gastrointestinal Drugs Growth Rate by Regions
2.2.1 Global Gastrointestinal Drugs Sales by Regions 2014-2019
2.2.2 Global Gastrointestinal Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Gastrointestinal Drugs Sales by Manufacturers
3.1.1 Gastrointestinal Drugs Sales by Manufacturers 2014-2019
3.1.2 Gastrointestinal Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Gastrointestinal Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Gastrointestinal Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Gastrointestinal Drugs Price by Manufacturers
3.4 Key Manufacturers Gastrointestinal Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Gastrointestinal Drugs Market
3.6 Key Manufacturers Gastrointestinal Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Prescription Gastrointestinal Drug Sales and Revenue (2014-2019)
4.1.2 OTC Gastrointestinal Drug Sales and Revenue (2014-2019)
4.2 Global Gastrointestinal Drugs Sales Market Share by Type
4.3 Global Gastrointestinal Drugs Revenue Market Share by Type
4.4 Gastrointestinal Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Gastrointestinal Drugs Sales by Application
6 United States
6.1 United States Gastrointestinal Drugs Breakdown Data by Company
6.2 United States Gastrointestinal Drugs Breakdown Data by Type
6.3 United States Gastrointestinal Drugs Breakdown Data by Application
7 European Union
7.1 European Union Gastrointestinal Drugs Breakdown Data by Company
7.2 European Union Gastrointestinal Drugs Breakdown Data by Type
7.3 European Union Gastrointestinal Drugs Breakdown Data by Application
8 China
8.1 China Gastrointestinal Drugs Breakdown Data by Company
8.2 China Gastrointestinal Drugs Breakdown Data by Type
8.3 China Gastrointestinal Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Gastrointestinal Drugs Breakdown Data by Company
9.2 Rest of World Gastrointestinal Drugs Breakdown Data by Type
9.3 Rest of World Gastrointestinal Drugs Breakdown Data by Application
9.4 Rest of World Gastrointestinal Drugs Breakdown Data by Countries
9.4.1 Rest of World Gastrointestinal Drugs Sales by Countries
9.4.2 Rest of World Gastrointestinal Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.1.4 Gastrointestinal Drugs Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.2.4 Gastrointestinal Drugs Product Introduction
10.2.5 Sanofi Recent Development
10.3 Bayer
10.3.1 Bayer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.3.4 Gastrointestinal Drugs Product Introduction
10.3.5 Bayer Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.4.4 Gastrointestinal Drugs Product Introduction
10.4.5 Pfizer Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.5.4 Gastrointestinal Drugs Product Introduction
10.5.5 GlaxoSmithKline Recent Development
10.6 Teva
10.6.1 Teva Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.6.4 Gastrointestinal Drugs Product Introduction
10.6.5 Teva Recent Development
10.7 Zeria(Tillotts)
10.7.1 Zeria(Tillotts) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.7.4 Gastrointestinal Drugs Product Introduction
10.7.5 Zeria(Tillotts) Recent Development
10.8 Perrigo
10.8.1 Perrigo Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.8.4 Gastrointestinal Drugs Product Introduction
10.8.5 Perrigo Recent Development
10.9 Boehringer Ingelheim
10.9.1 Boehringer Ingelheim Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.9.4 Gastrointestinal Drugs Product Introduction
10.9.5 Boehringer Ingelheim Recent Development
10.10 Purdue Pharma
10.10.1 Purdue Pharma Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Gastrointestinal Drugs
10.10.4 Gastrointestinal Drugs Product Introduction
10.10.5 Purdue Pharma Recent Development
10.11 C.B. Fleet
10.12 Abbott
10.13 Jiangzhong
10.14 Xian-Janssen
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Gastrointestinal Drugs Sales Channels
11.2.2 Gastrointestinal Drugs Distributors
11.3 Gastrointestinal Drugs Customers
12 Market Forecast
12.1 Global Gastrointestinal Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Gastrointestinal Drugs Sales Forecast by Type
12.3 Global Gastrointestinal Drugs Sales Forecast by Application
12.4 Gastrointestinal Drugs Forecast by Regions
12.4.1 Global Gastrointestinal Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Gastrointestinal Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Gastrointestinal Drugs Product Picture
Table Gastrointestinal Drugs Key Market Segments
Table Major Manufacturers Gastrointestinal Drugs Covered in This Report
Table Global Gastrointestinal Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Gastrointestinal Drugs Sales Market Shar by Type 2014-2025
Figure Prescription Gastrointestinal Drug Figures
Table Major Manufacturers of Prescription Gastrointestinal Drug
Figure OTC Gastrointestinal Drug Figures
Table Major Manufacturers of OTC Gastrointestinal Drug
Table Global Gastrointestinal Drugs Market Share by Application 2019-2025 (K Units)
Figure Chronic Gastritis Use Case
Figure Functional Dyspepsia Use Case
Figure Peptic Ulcer Use Case
Figure Acute Gastroenteritis Use Case
Figure Other Use Case
Figure Gastrointestinal Drugs Report Years Considered
Figure Global Gastrointestinal Drugs Market Size 2014-2025 (Million US$)
Figure Global Gastrointestinal Drugs Sales 2014-2019 (K Units)
Table Global Gastrointestinal Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Gastrointestinal Drugs Sales by Regions 2014-2019 (K Units)
Table Global Gastrointestinal Drugs Sales Market Share by Regions 2014-2019
Figure Global Gastrointestinal Drugs Sales Market Share by Regions 2014-2019
Figure Global Gastrointestinal Drugs Sales Market Share by Regions in 2019
Table Global Gastrointestinal Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Gastrointestinal Drugs Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Drugs Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Gastrointestinal Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Gastrointestinal Drugs Sales Share by Manufacturers in 2019
Table Gastrointestinal Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Gastrointestinal Drugs Revenue Share by Manufacturers (2014-2019)
Figure Gastrointestinal Drugs Value Share by Manufacturers in 2019
Table Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Gastrointestinal Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Gastrointestinal Drugs Plants/Factories Distribution
Table Key Manufacturers Gastrointestinal Drugs Area Served
Table Date of Key Manufacturers Enter into Gastrointestinal Drugs Market
Table Key Manufacturers Gastrointestinal Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Prescription Gastrointestinal Drug Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global OTC Gastrointestinal Drug Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Gastrointestinal Drugs Sales by Type (2014-2019) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Type (2014-2019)
Figure Global Gastrointestinal Drugs Sales Market Share by Type (2014-2019)
Figure Global Gastrointestinal Drugs Sales Market Share by Type in 2018
Table Global Gastrointestinal Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Gastrointestinal Drugs Revenue Share by Type (2014-2019)
Figure Global Gastrointestinal Drugs Revenue Market Share by Type (2014-2019)
Figure Global Gastrointestinal Drugs Revenue Market Share by Type in 2018
Table Gastrointestinal Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Gastrointestinal Drugs Sales by Application (2014-2019) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Application (2014-2019)
Figure Global Sales Gastrointestinal Drugs Market Share by Application (2014-2019)
Figure Global Sales Gastrointestinal Drugs Market Share by Application (2014-2019)
Figure United States Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Gastrointestinal Drugs Sales by Company (2014-2019) (K Units)
Table United States Gastrointestinal Drugs Sales Market Share by Company (2014-2019)
Figure United States Gastrointestinal Drugs Sales Market Share by Company in 2019
Table United States Gastrointestinal Drugs Sales by Type (2014-2019) (K Units)
Table United States Gastrointestinal Drugs Sales Market Share by Type (2014-2019)
Figure United States Gastrointestinal Drugs Market Share by Type in 2019
Table United States Gastrointestinal Drugs Sales by Application (2014-2019) (K Units)
Table United States Gastrointestinal Drugs Sales Market Share by Application (2014-2019)
Figure United States Gastrointestinal Drugs Market Share by Application in 2019
Figure European Union Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Gastrointestinal Drugs Sales by Company (2014-2019) (K Units)
Table European Union Gastrointestinal Drugs Sales Market Share by Company (2014-2019)
Figure European Union Gastrointestinal Drugs Sales Market Share by Company in 2019
Table European Union Gastrointestinal Drugs Sales by Type (2014-2019) (K Units)
Table European Union Gastrointestinal Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Gastrointestinal Drugs Market Share by Type
Table European Union Gastrointestinal Drugs Sales by Application (2014-2019) (K Units)
Table European Union Gastrointestinal Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Gastrointestinal Drugs Market Share by Application
Figure China Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Gastrointestinal Drugs Sales by Company (2014-2019) (K Units)
Table China Gastrointestinal Drugs Sales Market Share by Company (2014-2019)
Figure China Gastrointestinal Drugs Sales Market Share by Company in 2019
Table China Gastrointestinal Drugs Sales by Type (2014-2019) (K Units)
Table China Gastrointestinal Drugs Sales Market Share by Type (2014-2019)
Figure China Gastrointestinal Drugs Market Share by Type in 2019
Table China Gastrointestinal Drugs Sales by Application (2014-2019) (K Units)
Table China Gastrointestinal Drugs Sales Market Share by Application (2014-2019)
Figure China Gastrointestinal Drugs Market Share by Application in 2019
Figure Rest of World Gastrointestinal Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Gastrointestinal Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Gastrointestinal Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Gastrointestinal Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Gastrointestinal Drugs Sales Market Share by Company in 2019
Table Rest of World Gastrointestinal Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Gastrointestinal Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Gastrointestinal Drugs Market Share by Type in 2019
Table Rest of World Gastrointestinal Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Gastrointestinal Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Gastrointestinal Drugs Market Share by Application in 2019
Table Rest of World Gastrointestinal Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Gastrointestinal Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Gastrointestinal Drugs Sales Market Share by Countries in 2019
Table Rest of World Gastrointestinal Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Gastrointestinal Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Gastrointestinal Drugs Revenue Market Share by Countries in 2019
Figure Japan Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Gastrointestinal Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Gastrointestinal Drugs Revenue Growth Rate (2014-2019) (K Units)
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table AstraZeneca Gastrointestinal Drugs Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Sanofi Gastrointestinal Drugs Sales Market Share in Global Market
Table Sanofi Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Bayer Gastrointestinal Drugs Sales Market Share in Global Market
Table Bayer Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Pfizer Gastrointestinal Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Gastrointestinal Drugs Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Teva Company Details
Table Teva Description and Business Overview
Table Teva Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Teva Gastrointestinal Drugs Sales Market Share in Global Market
Table Teva Recent Development
Table Zeria(Tillotts) Company Details
Table Zeria(Tillotts) Description and Business Overview
Table Zeria(Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zeria(Tillotts) Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Zeria(Tillotts) Gastrointestinal Drugs Sales Market Share in Global Market
Table Zeria(Tillotts) Recent Development
Table Perrigo Company Details
Table Perrigo Description and Business Overview
Table Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Perrigo Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Perrigo Gastrointestinal Drugs Sales Market Share in Global Market
Table Perrigo Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Gastrointestinal Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Description and Business Overview
Table Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Gastrointestinal Drugs Sales Growth Rate (2014-2019)
Table Purdue Pharma Gastrointestinal Drugs Sales Market Share in Global Market
Table Purdue Pharma Recent Development
Table C.B. Fleet Company Details
Table Abbott Company Details
Table Jiangzhong Company Details
Table Xian-Janssen Company Details
Figure Gastrointestinal Drugs Value Chain
Table Gastrointestinal Drugs Distributors List
Table Gastrointestinal Drugs Customers List
Table Global Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Gastrointestinal Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Gastrointestinal Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Gastrointestinal Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Gastrointestinal Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Gastrointestinal Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure China Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure India Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Gastrointestinal Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Gastrointestinal Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs